GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » Cash And Cash Equivalents

Noevir Holdings Co (TSE:4928) Cash And Cash Equivalents : 円27,212 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co Cash And Cash Equivalents?

Noevir Holdings Co's quarterly cash and cash equivalents declined from Sep. 2023 (円28,883.00 Mil) to Dec. 2023 (円24,787.00 Mil) but then increased from Dec. 2023 (円24,787.00 Mil) to Mar. 2024 (円27,212.00 Mil).

Noevir Holdings Co's annual cash and cash equivalents declined from Sep. 2021 (円31,101.00 Mil) to Sep. 2022 (円29,747.00 Mil) and declined from Sep. 2022 (円29,747.00 Mil) to Sep. 2023 (円28,883.00 Mil).


Noevir Holdings Co Cash And Cash Equivalents Historical Data

The historical data trend for Noevir Holdings Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co Cash And Cash Equivalents Chart

Noevir Holdings Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,739.00 29,456.00 31,101.00 29,747.00 28,883.00

Noevir Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,595.00 27,443.00 28,883.00 24,787.00 27,212.00

Noevir Holdings Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Noevir Holdings Co  (TSE:4928) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Noevir Holdings Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Noevir Holdings Co (TSE:4928) Business Description

Traded in Other Exchanges
N/A
Address
6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines